Synonym
MK-866; MK866; MK 866;
IUPAC/Chemical Name
3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-isopropyl-1H-indol-2-yl)-2,2-dimethylpropanoic acid
InChi Key
QAOAOVKBIIKRNL-UHFFFAOYSA-N
InChi Code
InChI=1S/C27H34ClNO2S/c1-17(2)19-10-13-22-21(14-19)24(32-26(3,4)5)23(15-27(6,7)25(30)31)29(22)16-18-8-11-20(28)12-9-18/h8-14,17H,15-16H2,1-7H3,(H,30,31)
SMILES Code
CC(C)C1=CC2=C(N(CC3=CC=C(Cl)C=C3)C(CC(C)(C(O)=O)C)=C2SC(C)(C)C)C=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
472.08
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Trader DJ, Simanski S, Dickson P, Kodadek T. Establishment of a suite of assays that support the discovery of proteasome stimulators. Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):892-899. doi: 10.1016/j.bbagen.2017.01.003. Epub 2017 Jan 5. PMID: 28065760; PMCID: PMC5366797.
2: Garcia-Ramírez M, Hernández C, Palomer X, Vázquez-Carrera M, Simó R. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity. Acta Diabetol. 2016 Feb;53(1):109-18. doi: 10.1007/s00592-015-0759-3. Epub 2015 May 5. PMID: 25936740.
3: von Knethen A, Sha LK, Kuchler L, Heeg AK, Fuhrmann D, Heide H, Wittig I, Maier TJ, Steinhilber D, Brüne B. 5-Lipoxygenase contributes to PPARγ activation in macrophages in response to apoptotic cells. Cell Signal. 2013 Dec;25(12):2762-8. doi: 10.1016/j.cellsig.2013.08.045. Epub 2013 Sep 13. PMID: 24036216.
4: Petit A, Wang HT, Girard-Lauriault PL, Wertheimer MR, Antoniou J, Mwale F. Novel insights into the mechanism of decreased expression of type X collagen in human mesenchymal stem cells from patients with osteoarthritis cultured on nitrogen-rich plasma polymers: implication of cyclooxygenase-1. J Biomed Mater Res A. 2010 Sep 1;94(3):744-50. doi: 10.1002/jbm.a.32739. PMID: 20225218.
5: St-Gelais F, Ménard C, Congar P, Trudeau LE, Massicotte G. Postsynaptic injection of calcium-independent phospholipase A2 inhibitors selectively increases AMPA receptor-mediated synaptic transmission. Hippocampus. 2004;14(3):319-25. doi: 10.1002/hipo.10176. PMID: 15132431.
6: Knight J, Taylor GW, Wright P, Clare AS, Rowley AF. Eicosanoid biosynthesis in an advanced deuterostomate invertebrate, the sea squirt (Ciona intestinalis). Biochim Biophys Acta. 1999 Jan 4;1436(3):467-78. doi: 10.1016/s0005-2760(98)00153-2. PMID: 9989276.
7: Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology. 1992 Jul;103(1):177-85. doi: 10.1016/0016-5085(92)91111-g. PMID: 1612325.
8: Young PR, Bell RL, Lanni C, Summers JB, Brooks DW, Carter GW. Inhibition of leukotriene biosynthesis in the rat peritoneal cavity. Eur J Pharmacol. 1991 Dec 3;205(3):259-66. doi: 10.1016/0014-2999(91)90907-8. PMID: 1817962.
9: Vindlacheruvu RR, Rink TJ, Sage SO. Lack of evidence for a role for the lipoxygenase pathway in increases in cytosolic calcium evoked by ADP and arachidonic acid in human platelets. FEBS Lett. 1991 Nov 4;292(1-2):196-200. doi: 10.1016/0014-5793(91)80866-2. PMID: 1959606.
